2SEVENTY BIO
2seventy bio is an immuno-oncology cell therapy company that discovers and develops therapies used for cancer treatment. The company combines a deep knowledge of cancer cell biology and genetics with an understanding of the immune response to cancer to advance its pipeline. It was established in Cambridge, Massachusetts in 2021.
2SEVENTY BIO
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2021-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.2seventybio.com
Total Employee:
251+
Status:
Active
Contact:
617-675-7270
Email Addresses:
[email protected]
Total Funding:
170 M USD
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Cogent Biosciences
Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Employees Featured
Stock Details
Investors List
Madison Avenue Partners
Madison Avenue Partners investment in Post-IPO Equity - 2seventy bio
Casdin Capital
Casdin Capital investment in Post-IPO Equity - 2seventy bio
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Post-IPO Equity - 2seventy bio
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Equity - 2seventy bio
RTW Investments LLC
RTW Investments LLC investment in Post-IPO Equity - 2seventy bio
CaaS Capital Management
CaaS Capital Management investment in Post-IPO Equity - 2seventy bio
Newtyn Management
Newtyn Management investment in Post-IPO Equity - 2seventy bio
683 CAPITAL
683 CAPITAL investment in Post-IPO Equity - 2seventy bio
Janus Henderson Investors
Janus Henderson Investors investment in Post-IPO Equity - 2seventy bio
Heights Capital Management
Heights Capital Management investment in Post-IPO Equity - 2seventy bio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-14 | 2seventy bio plucks Turnstone Biologics exec Bernstein to be new CMO |
Official Site Inspections
http://www.2seventybio.com Semrush global rank: 2.14 M Semrush visits lastest month: 9.43 K
- Host name: ec2-34-228-209-155.compute-1.amazonaws.com
- IP address: 34.228.209.155
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
